MCI is a heterogeneous condition at the population level with different progression and reversion rates compared to clinical populations, highlighting the need for community-level validation of research criteria.
No takes yet. Share an insight, caveat, or question.
Community MCI progression rates warrant cautious prognosis; leaves open validation of clinical criteria in population settings.
Ganguli et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: